However, the combination of a thorough pelvic exam, transvaginal ultrasound, and a blood test for the tumor marker CA125 should be offered to woman who are at high risk of ovarian cancer and to women who have symptoms. For women at average risk, transvaginal ultrasound and testing for the tumor marker CA125 may help in diagnosis but are not used for routine screening.